Please assess the completion status of the following clinical trial:

Trial Title: Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. \> 18 years of age~2. Signed Informed Consent~3. Subjects diagnosed with Primary Pulmonary Hypertension or Myelofibrosis (primary or secondary)~Exclusion Criteria:~1. Anyone not meeting the above inclusion criteria~2. Pregnant women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PPH (Type: None): Subjects diagnosed with primary pulmonary hypertension (PPH)
- Myelofibrosis (Type: None): Subjects diagnosed with Primary or Secondary Myelofibrosis

Based on this trial design, predict the completion outcome and termination type (if applicable).